^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

gemcitabine oral (D07001)

i
Other names: D07001, D07001-F4, Inno-D07001
Associations
Trials
Company:
Synmosa Biopharma
Drug class:
DNA synthesis inhibitor
Related drugs:
Associations
Trials
3ms
New P3 trial
|
5-fluorouracil • capecitabine • irinotecan • leucovorin calcium • gemcitabine oral (D07001)
1year
Trial completion
|
gemcitabine oral (D07001)
almost4years
Study of D07001-Softgel Capsules in Subjects With Gastrointestinal Cancer in Dose-Escalation Phase and in Subjects With Biliary Tract Cancer in Dose-Expansion Phase (clinicaltrials.gov)
Recruiting --> Active, not recruiting | Trial completion date: May 2020 --> Apr 2022 | Trial primary completion date: Oct 2019 --> Jun 2021
Clinical • Enrollment closed • Trial completion date • Trial primary completion date
|
ALB (Albumin)
|
gemcitabine oral (D07001)